Status:
COMPLETED
Epidural Magnesium Sulfate for Post-thoracotomy Pain Control
Lead Sponsor:
National Research Institute of Tuberculosis and Lung Disease, Iran
Conditions:
Pain
Eligibility:
All Genders
16-85 years
Phase:
NA
Brief Summary
Pain after thoracotomy is very severe and may cause pulmonary complications. Thoracic epidural analgesia has greatly decreased the pain experience and its consequences. However, new ways of decreasing...
Eligibility Criteria
Inclusion
- American Society of Anesthesiologists physical statuses I-III
- Undergoing thoracotomy
Exclusion
- Known hypersensitivity to magnesium sulfate
- Renal failure
- Hepatic dysfunction
- Severe obesity
- Psychotic or neurologic diseases
- Currently taking opioid or calcium channel blocker
- AV block degree II or III
- Refused to participate in trial
Key Trial Info
Start Date :
December 1 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03343548
Start Date
December 1 2016
End Date
December 1 2017
Last Update
April 4 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shadi Baniasadi
Tehran, Iran, 19569-44413